RS
PCVX icon

Rakuten Securities’s Vaxcyte PCVX Stock Holding History

Rakuten Securities’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.87K Buy
101
+100
+10,000% +$5.43K ﹤0.01% 535
2026
Q1 		$58 Hold
1
– – ﹤0.01% 856
2025
Q4 		$46 Hold
1
– – ﹤0.01% 877
2025
Q3 		$36 Hold
1
– – ﹤0.01% 897
2025
Q2 		$33 Hold
1
– – ﹤0.01% 835
2025
Q1 		$38 Buy
+1
New +$80 ﹤0.01% 816
2024
Q3 		– Sell
-258
Closed -$19.5K – 771
2024
Q2 		$19.5K Buy
+258
New +$17.6K 0.01% 262

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rakuten Securities's PCVX Position: Q2 2026 in Review

Rakuten Securities increased its Vaxcyte (PCVX) stake by 10,000% in Q2 2026, buying an estimated $5.43K and bringing the position to 101 shares worth $5.87K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Rakuten Securities first reported a position in PCVX in Q2 2024 and has held it in 7 quarters since. The position peaked at $19.5K in Q2 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Rakuten Securities held 101 shares of Vaxcyte worth $5.87K as of Q2 2026.
  • Rakuten Securities bought 100 Vaxcyte shares in Q2 2026, an estimated $5.43K.
  • Vaxcyte made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #535 holding.
  • Rakuten Securities first reported a position in Vaxcyte in Q2 2024 and has held it in 7 quarters since.
  • Rakuten Securities's Vaxcyte position peaked at $19.5K in Q2 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.